Home LiteratureArticle Details
PMID: 10400826 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Cytokines in Gaucher's disease.

European cytokine network ·Vol. 10 ·No. 2 ·1999-06-00 ·Pages 205-10

Barak V, Acker M, Nisman B, Kalickman I, Abrahamov A, Zimran A, Yatziv S

Abstract

Gaucher's disease (GD) is characterized by hepatosplenomegaly, bone marrow infiltration, osteonecrosis, which may all be associated with the presence of pathological macrophages that contain undegraded glycosphingolipids. Levels of serum cytokines, which are soluble products of mononuclear phagocytes (MNP), were evaluated in 24 GD patients. Levels of interleukin-1beta (IL-1beta), interleukin-1 receptor antagonist (IL-1Ra), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and soluble interleukin-2 receptor (sIL-2R) in GD patients were significantly higher than in normal controls. We attempted to correlate cytokine levels with disease severity. Type I GD patients with more severe clinical manifestations had significantly higher levels of IL-1beta, IL-1Ra and IL-6, relative to type I patients with milder disease. Three patients homozygous for the 1448C mutation with neuropathic type III disease, had significantly higher levels of sIL-2R than type I patients or controls. We speculate that cytokine over-expression may relate to the pathophysiology of some of the clinical manifestations of GD. Thus, the elevated IL-1beta, TNF-alpha and IL-6 levels may induce the bone manifestations, the neutrophil chemotaxis and the increased incidence of hyper-gammaglobulinemia present in GD patients.

MeSH Terms
Chemotaxis, Leukocyte Child, Preschool Cytokines/blood,physiology Gaucher Disease/blood,classification,genetics,immunology,physiopathology Genotype Humans Hypergammaglobulinemia/etiology Infant Interleukin 1 Receptor Antagonist Protein Interleukin-1/blood Interleukin-6/blood Point Mutation Receptors, Interleukin-2/blood Severity of Illness Index Sialoglycoproteins/blood Solubility Splenectomy Tumor Necrosis Factor-alpha/analysis
Chemicals
Cytokines IL1RN protein, human Interleukin 1 Receptor Antagonist Protein Interleukin-1 Interleukin-6 Receptors, Interleukin-2 Sialoglycoproteins Tumor Necrosis Factor-alpha
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Barak V
Oncology Department, Hadassah University Hospital, Jerusalem, Israel.
Acker M
Nisman B
Kalickman I
Abrahamov A
Zimran A
Yatziv S
Article Info
Journal
European cytokine network
Abbr.
Eur Cytokine Netw
ISSN
1148-5493
Published
1999-06-00
Pages
205-10
Language
English
Region
France
NLM ID
9100879
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com